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Abstract
Background: The emergent international practice of involving consumers in health research is driven, in part, by
the growing share of health research that can only be applied in and emerge from knowledge that is shaped by
human values and societal contexts. This is the first investigation of its kind to identify the current prevalence,
challenges, enabling factors and range of approaches to consumer involvement in health and medical research in
Australia.
Methods: A nation-wide survey of research funding organisations and organisations that conduct research was
performed during 2008-2009.
Results: Marked variation in consumer involvement experience and perceptions exists between research funders
and researchers. Research funders were over eight times more likely than organisations conducting research to
involve consumers in identifying research needs and prioritising research topics. Across both groups, practical and
time constraints were reported as key challenges to involving consumers, while guidelines on consumer
involvement and evidence of effect were the most important potential enablers. More than a third of research
organisations indicated that when consumer involvement was a condition of research funding, it was an important
facilitator of involvement.
Conclusion: It is no longer simply enough to keep society informed of important scientific breakthroughs. If
Australian health research is to take into account important social contexts and consequences, it must involve
consumers. A set of minimum consumer involvement standards and associated guidelines, that are agreed and
routinely adopted, could ensure that consumers and the Australian community they represent, are given an
opportunity to shed light on experiences and local circumstance, and express views and concerns relevant to
health research.
Background
Health and medical research is scientific investigation
performed to better understand human health and
wellbeing [1]. Its goals are concerned with protecting
and improving health and quality of life; and it utilises
methods across the spectrum of investigations from
biomedical inquiry through to examining human beha-
viours [2]. Advances resulting from health and medical
research are the basis for improved health standards
and increased longevity, and are a primary driver of
innovation and increased productivity [3]. Justification
for universal progress in health science is motivated by
the need to address the rising prevalence of chronic
non-communicable disease worldwide [4].
The effects of health science research on society pre-
sent a mixed record of benefit and harm. There are cases
when health and medical research has led to increased
mortality and long-term suffering and hardship, such as
the exposure to many millions of people worldwide to
diethylstilboestrol, an oestrogenic medicine discovered to
have harmful long-term health consequences in three
g e n e r a t i o n st od a t e[ 5 ] .T h e r ea r ea l s o‘grey areas’ where
there is potential for benefit, but also conflicts of interest
with ethical or moral views, such as embryonic stem cell
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foresee the social effects of research or make value based
or contextual decisions about them alone, decisions
about health science should routinely be made in discus-
sions with the non-scientific community [6].
The importance of better connecting health and medical
research with society has been emphasised for several dec-
ades [7-9]. It is argued that, as health and medical research
is a social process, it should be informed by the interac-
tions of researchers and potential end beneficiaries, where
both groups exchange experiences, ideas, views and expec-
tations and combine this knowledge into acceptable, rea-
listic research objectives [10]. Consumer involvement is
believed to reduce opposition to implementation of the
research [11]; build commitment to the research findings
and needed organisational changes [12]; enhance the qual-
ity of the research design by improving the overall under-
standing of the solution [13]; help avoid development of
unacceptable health interventions; and provide necessary
expertise about the community processes that will be sup-
ported by the research findings [14].
Assessments of existing levels and types of consumer
involvement have been made by several groups overseas
[15,16]. Overall, they found a considerable proportion of
researchers had experience working with consumers and
that involving them required appropriate skill, resources
and time to develop and follow appropriate protocols [15].
This investigation sought to improve current knowledge
of consumer involvement in health and medical research
in Australia through an assessment of the prevalence of,
challenges with and facilitators to consumer involvement
in research and research funding organisations.
Method
This study was conducted over a 12-month period
beginning in August 2008; with ethics approval from the
University of Newcastle’s Human Research Ethics
Committee.
Participants & sample size
Research and research funding organisations were sur-
veyed to gain a broad perspective on consumer involve-
ment from both a governance and functional position.
The multiple stakeholder approach was adopted to
reduce potential bias from measuring consumer involve-
ment from a single-group perspective.
The study design featured relatively broad inclusion
criteria including all health and medical research organi-
sations conducting non-commercial human and biome-
dical research such as universities, independent medical
research institutes and health service research units.
Non-government research funding organisations such as
health charities that financially supported this type of
research were also included. Exclusion criteria included
commercial research groups; government agencies;
those that examined existing or proposed health policy
and international health research organisations. Health
charities without an external research funding program
were also excluded.
Research funders were identified from directories avail-
able from ProBono Australia [17], Auscharity [18] and
Philanthropy Australia [19]. Research organisations were
indentified from listings from NSW Office of Science and
Medical Research [20], National Health and Medical
Research Council [21], Universities Australia [22] and the
Australian Government Directory 14
th Edition [23].
A search of individual websites was also undertaken of
Australian health charities, universities, independent
medical research institutes and health service research
units to assess and/or confirm eligibility of identified
health research funders and organisations and to identify
additional organisations for inclusion. Three hundred
and six (306) organisations were identified as eligible; 89
research funders and 217 research organisations.
Survey instrument
The survey instrument was based on the international
literature on involving consumers in health research
[24,25]; and included eight primary items. Practical
aspects and the degree and nature of current organisa-
tional commitment for consumer involvement were
examined. Participants selected responses from a list of
13 areas known to engage consumers and nominated
additional areas of involvement (Table 1). The availabil-
ity of organisational resources, staff and protocols for
involving consumers were also investigated in three sub-
sequent ’Yes/No’ questions. Study participants were then
asked to prioritise a list of seven challenges of involving
consumers and submit other challenges they may have
experienced (Table 2). For the final item, participants
were asked to rate eight potential enabling factors they
believed would be most important in increasing their
organisations capacity to involve consumers or initiate
consumer involvement in research. They could also pro-
vide descriptions of other possible enablers.
Procedure
An information statement and survey were initially sent
by email to the Chief Executive Officer (CEO), Director
or a senior researcher of the 306 identified health
research and funding organisations. The email recipient
was asked to forward the request for study participation
t os o m e o n em o r es u i t a b l et oc o m p l e t et h es u r v e yo n
behalf of the organisation, if required.
Analysis
Quantitative data were analysed using SPSS version
16 for Windows [26] and are presented as frequencies,
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responses were examined to identify themes, and then
individual responses were classified according to these
themes.
Results
Response rate
As all primary databases of Australian research and
research funding organisations were interrogated, along
with extensive general searches, we are confident that
the large majority if not all eligible organisations were
identified and invited to participate. Responses were
received from 177, (58%) of the 306 invited organisa-
tions; representing 65% (n = 58) of the research funders
and 55% (n = 119) of the research organisations invited
to participate. The majority of individuals (88%) who
completed the survey on behalf of their organisation
were those originally contacted. These individuals were
considered most likely to have an understanding of con-
sumer involvement in research in their organisations i.e.
the CEO, Director or a senior researcher. The majority
were male (67%) and aged between 40 and 60 years of
age (88%). Most organisations had been established for
at least 10 years and had more than 10 employees.
Current consumer involvement
Participants were asked how their organisation currently
involved consumers (Table 1). The most frequently
reported involvement across both groups were: input into
organisational governance, such as membership on strate-
gic research planning or other high level committees such
as the Board of Directors; fund-raising for research;
and assisting with the communication and dissemination
of information about individual or organisation-wide
Table 1 Current involvement of consumers in research
Current involvement Research funding
organisation
Research
organisation
Total
Freq % Freq % Freq %
Input into organisational governance (organisation wide committee member) 44 60 72 75 116 65
Fundraising 33 57 45 38 78 44
Disseminate research information 33 57 45 38 78 44
Individual research project committee member 22 38 30 25 52 29
Identify research needs 35 60 8 7 43 24
Prioritise research 35 60 8 7 43 24
Input into acceptability of proposed research and likelihood of participation 14 24 25 21 39 22
Recruit participants 5 9 28 23 33 19
Other (ethics committee member) 0 0 28 23 28 16
Assist the development of research funding applications 8 14 5 4 13 7
Assist the development of research tools e.g. participant surveys or information sheets 3 5 8 7 11 6
Gather/facilitate research data collection 4 7 7 6 11 6
Member of research grant review panel 9 15 0 0 9 5
Contribute to the formulation of research policy such as funding guidelines 8 14 0 0 8 4
Other (felt laboratory research was not applicable) 0 0 8 7 8 4
Other (planning to in future) 2 3 2 2 4 2
Other (provide community talks) 0 0 2 2 2 1
Table 2 Challenges to involving consumers in research
Challenges Research
funding
organisation
Research
organisation
Total
Freq % Freq % Freq %
Practical and time constraints (developing lay information, consumer policies, office space, time to orientate
etc)
40 69 46 39 86 49
Clarification of consumer roles and responsibilities 25 43 40 34 65 37
Accessing consumers 27 46 31 26 58 33
Cost (reimbursement of out of pocket and other costs such as new office equipment etc) 20 34 1 1 21 12
Negative or complacent attitude of paid staff toward consumer involvement 7 12 14 12 21 12
Feedback requirements of consumers (recognition and appreciation requests) 13 22 7 6 20 11
Difficulty working with consumers (accepting opposing views, outspoken views etc) 5997 1 4 8
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research organisations (40%) involved consumers in fund
raising for research and disseminating information about
research. Across both groups, consumers were least likely
to be involved in research policy development, research
data collection and research grant review.
Overall, research funders were more likely to currently
involve consumers in research processes and structures.
They were also over eight times more likely than organi-
sations conducting research to involve consumers in
identifying research needs and prioritising research
topics; whilst organisations conducting research were
more than twice as likely to involve consumers in
recruiting research participants.
Organisational commitment
Overall, 15% (n = 25) of respondents reported that
resources were specifically allocated to consumer invol-
vement and 10% (n = 17) had a designated person
responsible for facilitating consumer involvement in
research. The availability of policies and/or protocols
that require consumer involvement was reported by 43%
(n = 51) of research organisations, who commonly
reported Ethics Committee Terms of Reference, com-
pared with 29% (n = 17) of research funders.
Challenges to involving consumers
Almost half (49%, n = 86) of all respondents reported
practical and time constraints (e.g. developing lay infor-
mation and/or consumer policies, providing office space,
time to orientate and communicate etc) as the most
important challenges to involving consumers, with a
higher percentage of research funders reporting this chal-
lenge (69% compared to 39% of research organisations).
As indicated in Table 2, other frequently reported chal-
lenges include clarification of consumer roles and
responsibilities; and the ability to access consumers. The
perceived costs of involving consumers and the feedback
requirements of consumers were reported as a challenge
by 34% and 22% of research funders, respectively, with
minimal reporting of these challenges by the participating
research organisations.
Perceived facilitators of consumer involvement
Sixty percent (n = 107) of all respondents selected
guidelines and other practical information and tools to
support consumer involvement as the most important
potential aid to involving consumers. A close second
was the need for evidence of organisational benefit for
involving consumers (58%, n = 104), which was reported
by a greater percentage of research organisations (65%,
n = 77) than research funders (46%, n = 27). Third was
the need for staff training to support consumer involve-
ment (39%, n = 69).
More than a third of research organisations indicated
that when consumer involvement was a condition of
research funding, it was an important facilitator of invol-
vement. Having an organisational driver (staff member
in management with the necessary passion, skill and
commitment toward consumer involvement) was more
important to research organisations than to research
funders. Of least importance as an enabler to consumer
involvement across both groups was endorsement of the
practice from other research organisations.
Limitations
The response rate of 58% does not reflect the practices of
over 40% of the initial sample, with possible systematic
differences between respondents and non-respondents in
terms of the nature and level of consumer involvement.
The study may have principally attracted responses
from organisations who wished to showcase their efforts
in involving consumers in research and may, therefore,
reflect a higher level of consumer involvement than is
actually practised.
Although key people, such as CEOs and other senior
staff, were targeted in this research, these single organi-
sational participants may not have been aware of all on-
site consumer involvement practices, especially those
from large organisations.
Discussion
A study examining consumer involvement in Australian
health and medical research is overdue. To our know-
ledge, this is the first investigation to identify the cur-
rent level, challenges, enabling factors and range of
approaches to consumer involvement in health and
medical research in Australia. There is, in theory, wide
acceptance of the potential benefits of involving consu-
mers in health and medical research in Australia [27],
but equally, in the practice of some groups, this study
has found a reluctance to test these potential benefits.
In the context of a growing array of new and increas-
ingly complex health care interventions that require pub-
lic acceptance and uptake, the current involvement of
consumers in Australian health and medical research can
perhaps best be described as ambivalent. Consumer par-
ticipation via committee membership such as an ethics
committee was reported by 75% of the research organisa-
tions. On face value this may appear to be a high level of
involvement however this cursory approach is unlikely to
provide a genuine opportunity for consumers to influ-
ence health research in Australia. In 1969 Arnstein [28]
simplified citizen participation using an eight-step ladder
of hierarchical participation that remains in common use
today. When participation is restricted to the low rungs
of the ladder it signifies ‘tokenism’ where any effect is
unlikely.
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is no single phase of research or research governance
that consumer involvement is best suited. Nor is there a
limit on the level of involvement that could be pursued
[24,29,30]. Consumer involvement includes almost any
kind of engagement between the researcher and consu-
mer including in research prioritisation processes, at the
design, planning, implementation and information disse-
mination stages of a research project, and in research
governance and policy [31].
A UK investigation has found comparable challenges
related to consumer involvement in research, including
lack of time and other practical and resource con-
straints. They also found a similar reluctance on the
part of basic biomedical researchers to accept consumer
involvement in research as being relevant to them [32].
Yet the involvement of consumers has contributed to
the relevance and quality of basic biomedical research
including the identification of previously unstudied pro-
blems such as comorbid chronic disease [33].
Other research on this topic has found that involving
consumers presents a change in the usual practice of
researchers [34]. However our findings, of the apparent
willingness of some research organisations to broadly
involve consumers, suggests that greater cooperation
between the two might be improved by addressing the
identified challenges, including the need to formally
investigate the advantages of involving consumers. Addi-
tionally, more Australian researchers may need to be
aware of the potential for involving consumers alongside
other members of a multidisciplinary research team
with a diverse range of skills, knowledge and expertise.
This is well accepted in the UK where the role of consu-
mers in research is given a high profile and allows con-
sumers to be recognised as genuine partners in research
decision making processes [35].
This study identified the most important perceived
facilitators of consumer involvement in research to be
practical tools that advise and assist involvement.
Australia essentially lacks a range of structures and
mechanisms found to be useful by other countries in
supporting consumer involvement. One example is the
INVOLVE organisation which is funded by the UK
Department of Health. INVOLVE was established to
promote consumer involvement in research and improve
the way that research is prioritised, commissioned,
undertaken, communicated and used. The organisation
provides resources and training for researchers and fun-
ders on how to involve members of the public. It also
supports consumers who are thinking about getting
involved in research. Through its website and publica-
tions it works with others to continuously build knowl-
edge and understanding of consumer involvement [35].
The availability of effective resources and training
programs, that facilitate the process of consumer partici-
pation, have been found to be important determinants
of the benefits derived from involvement [36].
Conclusion
The part played by science in society is becoming more
influential [37]. A national model framework for consu-
mer involvement in health research exists, on paper, in
Australia [27]. However its usefulness is diluted by a
number of structural and strategic factors including a
lack of resourcing; a failure to properly embed consumer
involvement into strategic research objectives and fund-
ing and review processes; an absence of mechanisms to
fully support involvement; failure to link consumer
involvement to other strategic goals and unclear respon-
sibility for implementing consumer involvement among
key stakeholders.
As a considerable proportion of new scientific knowl-
edge can only be applied in and emerge from processes
that are underpinned by human values and societal con-
texts, and given the heightened political importance of
reducing health care costs, it may be timely to give an
increasing focus and commitment to consumer involve-
ment in health and medical research in Australia.
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